Cargando…

Risk-Factor Analysis of Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation

The objective of this study was to investigate the main risk factors for poor graft function (PGF) after allogeneic hematopoietic stem cell transplantation (allo-HSCT), to allow the improvement of transplantation outcomes through preventive measures. Clinical data for 124 patients who received allo-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiao, Yang, Song, Jiayin, Jiang, Zujun, Li, Yonghua, Gao, Yang, Xu, Wenning, Lu, Ziyuan, Wang, Yaochun, Xiao, Haowen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2014
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4021098/ https://www.ncbi.nlm.nih.gov/pubmed/24834012 http://dx.doi.org/10.7150/ijms.6337

Ejemplares similares

Optimizing allogeneic grafts in hematopoietic stem cell transplantation
por: Xu, Zheng‐Li, et al.
Publicado: (2021)

Advances in the understanding of poor graft function following allogeneic hematopoietic stem-cell transplantation
por: Chen, Juan, et al.
Publicado: (2020)

Eltrombopag for the Treatment of Allogeneic Hematopoietic Stem Cell Transplantation-Related Poor Graft Function
por: Arslan Davulcu, Eren, et al.
Publicado: (2023)

Aberrant T cell responses in the bone marrow microenvironment of patients with poor graft function after allogeneic hematopoietic stem cell transplantation
por: Kong, Yuan, et al.
Publicado: (2017)

Use of Eltrombopag in Improving Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation
por: Master, Samip, et al.
Publicado: (2018)

Successful treatment of secondary poor graft function post allogeneic hematopoietic stem cell transplantation with eltrombopag
por: Tang, Cen, et al.
Publicado: (2018)

Recent Advancements in Poor Graft Function Following Hematopoietic Stem Cell Transplantation
por: Man, Yan, et al.
Publicado: (2022)

Allogeneic hematopoietic stem-cell transplantation for myelofibrosis
por: Zhang, Lining, et al.
Publicado: (2020)

Management of dyslipidemia after allogeneic hematopoietic stem cell transplantation
por: Lu, Yingxue, et al.
Publicado: (2022)

The predictive value of pulmonary function test before transplantation for chronic pulmonary graft-versus-host-disease after allogeneic hematopoietic stem cell transplantation
por: Yang, Lingyi, et al.
Publicado: (2022)

Epileptic Seizures After Allogeneic Hematopoietic Stem Cell Transplantation
por: Wang, Zhuo, et al.
Publicado: (2021)

Methotrexate for the Treatment of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation
por: Nassar, Amr, et al.
Publicado: (2014)

Metabolic Targets for Improvement of Allogeneic Hematopoietic Stem Cell Transplantation and Graft-vs.-Host Disease
por: Tijaro-Ovalle, Natalia M., et al.
Publicado: (2019)

Parvovirus B19‐associated graft failure after allogeneic hematopoietic stem cell transplantation
por: Rattani, Nabila, et al.
Publicado: (2021)

Second Allogeneic Hematopoietic Stem Cell Transplantation for Hemophagocytic Syndrome with Engraftment Failure
por: Jiang, Fan, et al.
Publicado: (2022)

Advances in Allogeneic Hematopoietic Stem Cell Transplantation for Acute Leukemia
por: Nannya, Yasuhito, et al.
Publicado: (2022)

Allogeneic hematopoietic stem cell transplantation in China: where we are and where to go
por: Lv, Meng, et al.
Publicado: (2012)

Allogeneic hematopoietic cell transplantation, the microbiome, and graft-versus-host disease
por: van Lier, Yannouck F., et al.
Publicado: (2023)

Allogeneic hematopoietic stem cell transplantation in mycosis fungoides
por: Atalla, Angelo, et al.
Publicado: (2013)

Epigenetic therapy in allogeneic hematopoietic stem cell transplantation
por: Bashir, Qaiser, et al.
Publicado: (2013)

Autoimmunity Following Allogeneic Hematopoietic Stem Cell Transplantation
por: Buxbaum, Nataliya Prokopenko, et al.
Publicado: (2020)

Immune Reconstitution and Graft-Versus-Host Reactions in Rat Models of Allogeneic Hematopoietic Cell Transplantation
por: Zinöcker, Severin, et al.
Publicado: (2012)

Etanercept for steroid-refractory acute graft versus host disease following allogeneic hematopoietic stem cell transplantation
por: Park, Joo Han, et al.
Publicado: (2014)

Encephalopathy in pediatric patients after allogeneic hematopoietic stem cell transplantation is associated with a poor prognosis
por: Woodard, P, et al.
Publicado: (2004)

Muscle Cramps and Neuropathies in Patients with Allogeneic Hematopoietic Stem Cell Transplantation and Graft-versus-Host Disease
por: Kraus, Peter D., et al.
Publicado: (2012)

Helper Innate Lymphoid Cells in Allogenic Hematopoietic Stem Cell Transplantation and Graft Versus Host Disease
por: Quatrini, Linda, et al.
Publicado: (2020)

Dermoscopy of Cutaneous Graft-Versus-Host-Disease in Patients After Allogeneic Hematopoietic Stem Cell Transplantation
por: Kaminska-Winciorek, Grażyna, et al.
Publicado: (2020)

Role of interferon-γ in immune-mediated graft failure after allogeneic hematopoietic stem cell transplantation
por: Merli, Pietro, et al.
Publicado: (2019)

Incidence, Management, and Prognosis of Graft Failure and Autologous Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation
por: Park, Jun-Hong, et al.
Publicado: (2021)

Mutations in epigenetic regulators are involved in acute lymphoblastic leukemia relapse following allogeneic hematopoietic stem cell transplantation
por: Xiao, Haowen, et al.
Publicado: (2015)

Association of Persistent Minimal Residual Disease with Poor Outcomes of Patients with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
por: Liu, Jing, et al.
Publicado: (2018)

A case of lupus miliaris disseminatus faciei after allogeneic hematopoietic stem cell transplantation
por: Zhang, Si, et al.
Publicado: (2019)

Clinical features, pathophysiology, and therapy of poor graft function post–allogeneic stem cell transplantation
por: Prabahran, Ashvind, et al.
Publicado: (2022)

Efficacy and safety of mesenchymal stem cells treatment for multidrug-resistant graft-versus-host disease after haploidentical allogeneic hematopoietic stem cell transplantation
por: Shen, Meng-Zhu, et al.
Publicado: (2022)

Is there a role for allogeneic hematopoietic stem cell transplantation for refractory follicular lymphoma?
por: Yang, Yang, et al.
Publicado: (2022)

Is It Better to Mobilize Hematopoietic Stem Cells With Pegfilgrastim in Healthy Donors During Allogeneic Hematopoietic Stem Cell Transplantation?
por: Li, Jiali, et al.
Publicado: (2020)

Allogeneic Hematopoietic Stem Cell Transplantation in Extranodal Natural Killer/T-cell Lymphoma
por: Peng, Yin-yin, et al.
Publicado: (2021)

Immune reconstitution and survival of patients after allogeneic hematopoietic stem cell transplantation from older donors
por: Jiang, Peiyao, et al.
Publicado: (2022)

Multivariate analysis of factors predicting surgical intervention for hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation
por: Yang, Wen-Bo, et al.
Publicado: (2021)

P1548: CMVR AND BSI ALONE AREN’T POOR PROGNOSIS RISK FACTORS IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION, BUT THEIR COMBINATION IS
por: Ren, Jinhua, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_e63ag5q0bsvf43oftdnb9h6mie